Galp Energia, SGPS, S.A. Q3 2024 Earnings Conference Call Company Overview Galp Energia, SGPS, S.A. (OTCPK:GLPEF) recently held its Q3 2024 Earnings Conference Call on October 28, 2024 at 7:00 AM ET. The company is known for its focus on professionalism, education, profitability, and intensity in the energy sector. Key Participants The conference call featured…
Welcome to the Wacky World of CVR Energy! What Happened in Sugar Land? So, did you hear the latest news about CVR Energy, Inc.? Well, it looks like they hit a bit of a rough patch in the third quarter of 2024. The company announced a net loss of $124 million, which translates to $1.24…
Centrus Energy Reports Third Quarter 2024 Results Selected as Awardee for HALEU Production and Deconversion Contracts Expanding on Centrus Energy’s Recent Achievements Centrus Energy Corp. has been chosen by the U.S. Department of Energy (“DOE”) as an awardee for High Assay Low-Enriched Uranium (“HALEU”) production and HALEU deconversion contracts. This is a significant accomplishment for…
LOS ANGELES, Oct. 28, 2024 /PRNewswire/ — GreenPower Motor Company Inc. (NASDAQ: GP) (TSXV: GPV) (“GreenPower”, or the “Company”), a leading manufacturer and distributor of purpose-built, all-electric, zero-emission medium and heavy-duty vehicles serving the cargo and delivery market, shuttle and transit space, and school bus sector, today announced that it intends to offer to sell…
Centerspace Announces Financial Results for Q3 2024 MINNEAPOLIS, Oct. 28, 2024 /PRNewswire/ — Centerspace (NYSE: CSR) announced today its financial and operating results for the three and nine months ended September 30, 2024. Financial Results Centerspace reported its Net Income (Loss), Funds from Operations (“FFO”), and Core FFO on a per diluted share basis for…
NewAmsterdam Pharma to Present Data on Obicetrapib at AHA Scientific Sessions NAARDEN, The Netherlands and MIAMI, Oct. 28, 2024 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol…
Charmingly Eccentric Economists: A Look into Jamie Dimon’s Inflation Predictions JPMorgan Chase Chair and CEO, Jamie Dimon, Sparks Conversation on Inflation At the American Bankers Association Annual Convention in New York, Jamie Dimon, the Chair and CEO of JPMorgan Chase, made a statement that caught the attention of many. Dimon suggested that inflation might not…
Feeling the Effects of a Challenging Quarter A Look at the Numbers CARTHAGE, Mo. , Oct. 28, 2024 /PRNewswire/ — 3Q sales of $1.1 billion, a 6% decrease vs 3Q23 3Q EPS of $.33; 3Q adjusted1 EPS of $.32, a $.04 decrease vs adjusted1 3Q23 EPS 2024 EPS guidance is ($3.56)–($3.71), including impact of non-cash…
